Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2026 Feb 18;16:6942. doi: 10.1038/s41598-026-40190-6

Retraction Note: Novel prognostic biomarkers in small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications

Yuting Li 1,#, Chen Song 2,#, Haijun Wang 3, Wenyu Di 3, Yangyang Chen 4, Yuanyuan Hu 1, Peiheng Li 4, Jie Chen 4, Yanfeng Ren 5,, Jing Gong 6,7,, Qinghua Wang 1,5,
PMCID: PMC12916812  PMID: 41708797

Retraction of: Scientific Reports 10.1038/s41598-025-00222-z, published online 04 May 2025

The Authors have retracted this Article.

Following publication, concerns were raised regarding the robustness and reproducibility of the analyses of the mutational signature section presented in the study. Upon internal review, the Authors have identified issues that compromise the reliability of the reported findings:

  1. The de- novo mutation signature extraction method employed in the original study is not optimally suited for the specific somatic mutation data of Small Cell Lung Cancer (SCLC).

  2. The re-analysis indicated that methodological biases occurred during the processing and presentation of mutation signature activity and the subsequent integration of genomic with clinical data. These discrepancies led to results that are difficult to replicate with the necessary statistical robustness.

In light of these issues, the Authors no longer have confidence in the conclusions of the mutational signature section.

All Authors agree with the retraction and its wording.

Contributor Information

Yanfeng Ren, Email: renyf@sdsmu.edu.cn.

Jing Gong, Email: gongjing1990@163.com.

Qinghua Wang, Email: wangqinghua@sdsmu.edu.cn.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES